Valneva SE is a French specialty vaccine company dedicated to developing and commercialising innovative prophylactic vaccines. Its primary aim is to protect people from infectious diseases through new preventative solutions, operating internationally.
Operating within the biotechnology and healthcare sector, Valneva SE focuses on developing vaccines for diseases with significant unmet medical needs. Its approach aims to provide effective preventative measures that contribute to global public health.
Keep up to date on the latest share price changes by adding VLA.PA stock to your eToro virtual portfolio.
This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.